Table 1. Clinical outcomes in OLK and mtOLK.

ID	Lesion	Epithelialdysplasia	FISHscore	Recurrent	Newlyformed	Follow-up (months)
1	OLK	ND	0	NA	NA	27
2	OLK	MiD	0	(+)	(−)	47
3	OLK	MiD	0	NA	NA	29
4	OLK	MiD	0	(+)	(−)	20
5	OLK	MoD	0	(+)	(−)	37
6	OLK	MoD	0.	(−)	(−)	30
7	OLK	SD	0	(+)	(−)	42
8	OLK	SD	0	NA	NA	32
9	OLK	SD	0	(−)	(−)	29
10	OLK	SD	2	(−)	(−)	30
11	mtOLK	SCC	0	(−)	(+)	36
12	mtOLK	SCC	2	(−)	(−)	28
13	mtOLK	SCC	1	(−)	(−)	33
14	mtOLK	SCC	1	NA	NA	21
15	mtOLK	SCC	2	(−)	(−)	21

OLK, oral leukoplakia; mtOLK, malignant transformed oral leukoplakia; ND, no dysplasia; MiD, mild dysplasia; MoD, moderate dysplasia; SD, severe dysplasia; SCC, squamous cell carcinoma; NA, not available.